Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.65 |
| ▸ | CA9 | Q16790 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLS | O94925 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31344151 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL29516478 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL3823000 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL2840942 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL756918 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL294711 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL20241693 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL20241380 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL8914547 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS | |
| SCHEMBL28365908 | 1.00 | CA1 (0.65) | CA1CA9ALDH1A1GLS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118574868-A | Triblock copolymer and preparation method and application thereof | 人工自然有限公司 | 2024-08-30 | — | — | CN | claimed |
| EP-2812316-B1 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES | KAO CORP (JP) | 2016-08-17 | — | — | EP | claimed |
| US-8349970-B2 | Phase change composition for printing | XEROX CORPORATION (US) | 2013-01-08 | — | — | US | claimed |
| EP-2163950-B1 | Toner comprising epoxidized polyester and method of manufacture | XEROX CORP (US) | 2012-12-19 | — | — | EP | claimed |
| US-8278020-B2 | Polyester synthesis | XEROX CORPORATION (US) | 2012-10-02 | — | — | US | claimed |
| US-20120128881-A1 | PHASE CHANGE COMPOSITION FOR PRINTING | XEROX CORPORATION (US) | 2012-05-24 | — | — | US | claimed |
| EP-2163950-A1 | Toner comprising epoxidized polyester and method of manufacture | Xerox Corporation (US) | 2010-03-17 | — | — | EP | claimed |
| US-20100062358-A1 | POLYESTER SYNTHESIS | XEROX CORPORATION (US) | 2010-03-11 | — | — | US | claimed |
| JP-11269482-A | — | — | None | — | — | JP | disclosed |
| CN-118574868-A | Triblock copolymer and preparation method and application thereof | 人工自然有限公司 | 2024-08-30 | — | — | CN | disclosed |
| EP-3844269-A1 | PRODUCTION OF NON-NATIVE MONOUNSATURATED FATTY ACIDS IN BACTERIA | Genomatica, Inc. (US) | 2021-07-07 | — | — | EP | disclosed |
| US-20210189373-A1 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | AGAIN BIO APS (DK) | 2021-06-24 | — | — | US | disclosed |
| WO-2020047088-A1 | PRODUCTION OF NON-NATIVE MONOUNSATURATED FATTY ACIDS IN BACTERIA | GENOMATICA, INC. (US) | 2020-03-05 | — | — | WO | disclosed |
| US-10159655-B2 | Agent for inhibiting odor of pyrazine derivatives | KAO CORPORATION (JP) | 2018-12-25 | — | — | US | disclosed |
| US-20100055750-A1 | POLYESTER SYNTHESIS | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20090280429-A1 | POLYESTER SYNTHESIS | XEROX CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
| EP-2116608-A2 | Polyester synthesis | Xerox Corporation (US) | 2009-11-11 | — | — | EP | disclosed |
| EP-1806978-A1 | STEREOSELECTIVE PREPARATION OF GAMMA-LACTONES | V. Mane Fils (FR) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006048551-A1 | STEREOSELECTIVE PREPARATION OF GAMMA-LACTONES | V. MANE FILS (FR) | 2006-05-11 | — | — | WO | disclosed |
| JP-H11269482-A | ORCHID-LIKE PERFUME COMPOSITION | SHISEIDO CO LTD | 1999-10-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10159655-B2 | Agent for inhibiting odor of pyrazine derivatives | OR10J3, OR51E2, TAS2R5 | CA1 2350/4885CA9 3745/4885ALDH1A1 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.